PMC:7074424 / 15638-16072 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"359","span":{"begin":55,"end":60},"obj":"Gene"},{"id":"360","span":{"begin":131,"end":136},"obj":"Gene"},{"id":"361","span":{"begin":90,"end":95},"obj":"Species"},{"id":"364","span":{"begin":290,"end":297},"obj":"Chemical"},{"id":"365","span":{"begin":347,"end":365},"obj":"Disease"},{"id":"366","span":{"begin":374,"end":388},"obj":"Disease"},{"id":"367","span":{"begin":109,"end":113},"obj":"CellLine"},{"id":"368","span":{"begin":237,"end":239},"obj":"CellLine"},{"id":"369","span":{"begin":394,"end":396},"obj":"CellLine"}],"attributes":[{"id":"A359","pred":"tao:has_database_id","subj":"359","obj":"Gene:59272"},{"id":"A360","pred":"tao:has_database_id","subj":"360","obj":"Gene:59272"},{"id":"A361","pred":"tao:has_database_id","subj":"361","obj":"Tax:9606"},{"id":"A364","pred":"tao:has_database_id","subj":"364","obj":"MESH:D005947"},{"id":"A365","pred":"tao:has_database_id","subj":"365","obj":"MESH:C000657245"},{"id":"A366","pred":"tao:has_database_id","subj":"366","obj":"MESH:D001102"},{"id":"A367","pred":"tao:has_database_id","subj":"367","obj":"CVCL:0063"},{"id":"A368","pred":"tao:has_database_id","subj":"368","obj":"CVCL:4582"},{"id":"A369","pred":"tao:has_database_id","subj":"369","obj":"CVCL:4582"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" al. identified 18 small molecules that targeted the S-ACE-2-mediated entry of virus into human cell.[53] In 293T cells expressing ACE-2, one of these agents (VE607) showed a significant inhibition of SARS-pseudovirus entry.[53] In Vero E6 cells, two other molecules tetra-O-galloyl beta-D-glucose and luteolin also inhibited SARS-pseudovirus and SARS-CoV infection.[53] In virus-infected Vero E6 cells, a siRNA against the S sequence"}

    2_test

    {"project":"2_test","denotations":[{"id":"32201449-15380189-47217068","span":{"begin":102,"end":104},"obj":"15380189"},{"id":"32201449-15380189-47217069","span":{"begin":225,"end":227},"obj":"15380189"},{"id":"32201449-15380189-47217070","span":{"begin":367,"end":369},"obj":"15380189"},{"id":"T73009","span":{"begin":102,"end":104},"obj":"15380189"},{"id":"T80388","span":{"begin":225,"end":227},"obj":"15380189"},{"id":"T87331","span":{"begin":367,"end":369},"obj":"15380189"}],"text":" al. identified 18 small molecules that targeted the S-ACE-2-mediated entry of virus into human cell.[53] In 293T cells expressing ACE-2, one of these agents (VE607) showed a significant inhibition of SARS-pseudovirus entry.[53] In Vero E6 cells, two other molecules tetra-O-galloyl beta-D-glucose and luteolin also inhibited SARS-pseudovirus and SARS-CoV infection.[53] In virus-infected Vero E6 cells, a siRNA against the S sequence"}

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T406","span":{"begin":25,"end":34},"obj":"CHEBI:36357;CHEBI:36357"},{"id":"T405","span":{"begin":55,"end":60},"obj":"G_3;PG_10;PR:000003622"},{"id":"T404","span":{"begin":79,"end":84},"obj":"NCBITaxon:10239"},{"id":"T403","span":{"begin":90,"end":95},"obj":"SP_6;NCBITaxon:9606"},{"id":"T402","span":{"begin":109,"end":113},"obj":"CL_4"},{"id":"T401","span":{"begin":120,"end":130},"obj":"GO:0010467"},{"id":"T400","span":{"begin":131,"end":136},"obj":"G_3;PG_10;PR:000003622"},{"id":"T399","span":{"begin":201,"end":205},"obj":"SP_10"},{"id":"T398","span":{"begin":206,"end":217},"obj":"NCBITaxon:11886"},{"id":"T397","span":{"begin":232,"end":236},"obj":"CL_6"},{"id":"T396","span":{"begin":257,"end":266},"obj":"CHEBI:36357;CHEBI:36357"},{"id":"T395","span":{"begin":267,"end":272},"obj":"CHEBI:75055;CHEBI:75055"},{"id":"T394","span":{"begin":272,"end":275},"obj":"CHEBI:17634;CHEBI:17634"},{"id":"T393","span":{"begin":275,"end":297},"obj":"CHEBI:24183;CHEBI:24183"},{"id":"T392","span":{"begin":302,"end":310},"obj":"CHEBI:15864;CHEBI:15864"},{"id":"T391","span":{"begin":326,"end":330},"obj":"SP_10"},{"id":"T390","span":{"begin":331,"end":342},"obj":"NCBITaxon:11886;SO:0000336"},{"id":"T389","span":{"begin":347,"end":355},"obj":"SP_10"},{"id":"T388","span":{"begin":374,"end":379},"obj":"NCBITaxon:10239"},{"id":"T387","span":{"begin":389,"end":393},"obj":"CL_6"},{"id":"T386","span":{"begin":406,"end":411},"obj":"SO:0000646"}],"text":" al. identified 18 small molecules that targeted the S-ACE-2-mediated entry of virus into human cell.[53] In 293T cells expressing ACE-2, one of these agents (VE607) showed a significant inhibition of SARS-pseudovirus entry.[53] In Vero E6 cells, two other molecules tetra-O-galloyl beta-D-glucose and luteolin also inhibited SARS-pseudovirus and SARS-CoV infection.[53] In virus-infected Vero E6 cells, a siRNA against the S sequence"}

    LitCovid_Glycan-Motif-Structure

    {"project":"LitCovid_Glycan-Motif-Structure","denotations":[{"id":"T1","span":{"begin":290,"end":297},"obj":"https://glytoucan.org/Structures/Glycans/G15021LG"}],"text":" al. identified 18 small molecules that targeted the S-ACE-2-mediated entry of virus into human cell.[53] In 293T cells expressing ACE-2, one of these agents (VE607) showed a significant inhibition of SARS-pseudovirus entry.[53] In Vero E6 cells, two other molecules tetra-O-galloyl beta-D-glucose and luteolin also inhibited SARS-pseudovirus and SARS-CoV infection.[53] In virus-infected Vero E6 cells, a siRNA against the S sequence"}

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T143","span":{"begin":96,"end":100},"obj":"Body_part"},{"id":"T144","span":{"begin":114,"end":119},"obj":"Body_part"},{"id":"T145","span":{"begin":240,"end":245},"obj":"Body_part"},{"id":"T146","span":{"begin":290,"end":297},"obj":"Body_part"},{"id":"T147","span":{"begin":397,"end":402},"obj":"Body_part"}],"attributes":[{"id":"A143","pred":"fma_id","subj":"T143","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A144","pred":"fma_id","subj":"T144","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A145","pred":"fma_id","subj":"T145","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A146","pred":"fma_id","subj":"T146","obj":"http://purl.org/sig/ont/fma/fma82743"},{"id":"A147","pred":"fma_id","subj":"T147","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":" al. identified 18 small molecules that targeted the S-ACE-2-mediated entry of virus into human cell.[53] In 293T cells expressing ACE-2, one of these agents (VE607) showed a significant inhibition of SARS-pseudovirus entry.[53] In Vero E6 cells, two other molecules tetra-O-galloyl beta-D-glucose and luteolin also inhibited SARS-pseudovirus and SARS-CoV infection.[53] In virus-infected Vero E6 cells, a siRNA against the S sequence"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T79","span":{"begin":201,"end":205},"obj":"Disease"},{"id":"T80","span":{"begin":326,"end":330},"obj":"Disease"},{"id":"T81","span":{"begin":347,"end":365},"obj":"Disease"},{"id":"T82","span":{"begin":347,"end":351},"obj":"Disease"},{"id":"T83","span":{"begin":356,"end":365},"obj":"Disease"}],"attributes":[{"id":"A79","pred":"mondo_id","subj":"T79","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A80","pred":"mondo_id","subj":"T80","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A81","pred":"mondo_id","subj":"T81","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A82","pred":"mondo_id","subj":"T82","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A83","pred":"mondo_id","subj":"T83","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":" al. identified 18 small molecules that targeted the S-ACE-2-mediated entry of virus into human cell.[53] In 293T cells expressing ACE-2, one of these agents (VE607) showed a significant inhibition of SARS-pseudovirus entry.[53] In Vero E6 cells, two other molecules tetra-O-galloyl beta-D-glucose and luteolin also inhibited SARS-pseudovirus and SARS-CoV infection.[53] In virus-infected Vero E6 cells, a siRNA against the S sequence"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T173","span":{"begin":16,"end":18},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T174","span":{"begin":79,"end":84},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T175","span":{"begin":90,"end":100},"obj":"http://purl.obolibrary.org/obo/CLO_0053065"},{"id":"T176","span":{"begin":109,"end":113},"obj":"http://purl.obolibrary.org/obo/CLO_0050894"},{"id":"T177","span":{"begin":109,"end":113},"obj":"http://purl.obolibrary.org/obo/CLO_0051650"},{"id":"T178","span":{"begin":109,"end":113},"obj":"http://purl.obolibrary.org/obo/CLO_0052052"},{"id":"T179","span":{"begin":114,"end":119},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T180","span":{"begin":173,"end":174},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T181","span":{"begin":232,"end":245},"obj":"http://purl.obolibrary.org/obo/CLO_0051719"},{"id":"T182","span":{"begin":374,"end":379},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T183","span":{"begin":389,"end":402},"obj":"http://purl.obolibrary.org/obo/CLO_0051719"},{"id":"T184","span":{"begin":404,"end":405},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":" al. identified 18 small molecules that targeted the S-ACE-2-mediated entry of virus into human cell.[53] In 293T cells expressing ACE-2, one of these agents (VE607) showed a significant inhibition of SARS-pseudovirus entry.[53] In Vero E6 cells, two other molecules tetra-O-galloyl beta-D-glucose and luteolin also inhibited SARS-pseudovirus and SARS-CoV infection.[53] In virus-infected Vero E6 cells, a siRNA against the S sequence"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T148","span":{"begin":25,"end":34},"obj":"Chemical"},{"id":"T149","span":{"begin":257,"end":266},"obj":"Chemical"},{"id":"T150","span":{"begin":275,"end":297},"obj":"Chemical"},{"id":"T151","span":{"begin":283,"end":297},"obj":"Chemical"},{"id":"T152","span":{"begin":283,"end":287},"obj":"Chemical"},{"id":"T153","span":{"begin":288,"end":297},"obj":"Chemical"},{"id":"T156","span":{"begin":290,"end":297},"obj":"Chemical"},{"id":"T157","span":{"begin":302,"end":310},"obj":"Chemical"}],"attributes":[{"id":"A148","pred":"chebi_id","subj":"T148","obj":"http://purl.obolibrary.org/obo/CHEBI_25367"},{"id":"A149","pred":"chebi_id","subj":"T149","obj":"http://purl.obolibrary.org/obo/CHEBI_25367"},{"id":"A150","pred":"chebi_id","subj":"T150","obj":"http://purl.obolibrary.org/obo/CHEBI_24183"},{"id":"A151","pred":"chebi_id","subj":"T151","obj":"http://purl.obolibrary.org/obo/CHEBI_15903"},{"id":"A152","pred":"chebi_id","subj":"T152","obj":"http://purl.obolibrary.org/obo/CHEBI_10545"},{"id":"A153","pred":"chebi_id","subj":"T153","obj":"http://purl.obolibrary.org/obo/CHEBI_17634"},{"id":"A154","pred":"chebi_id","subj":"T153","obj":"http://purl.obolibrary.org/obo/CHEBI_4167"},{"id":"A155","pred":"chebi_id","subj":"T153","obj":"http://purl.obolibrary.org/obo/CHEBI_42758"},{"id":"A156","pred":"chebi_id","subj":"T156","obj":"http://purl.obolibrary.org/obo/CHEBI_17234"},{"id":"A157","pred":"chebi_id","subj":"T157","obj":"http://purl.obolibrary.org/obo/CHEBI_15864"},{"id":"A158","pred":"chebi_id","subj":"T157","obj":"http://purl.obolibrary.org/obo/CHEBI_57545"}],"text":" al. identified 18 small molecules that targeted the S-ACE-2-mediated entry of virus into human cell.[53] In 293T cells expressing ACE-2, one of these agents (VE607) showed a significant inhibition of SARS-pseudovirus entry.[53] In Vero E6 cells, two other molecules tetra-O-galloyl beta-D-glucose and luteolin also inhibited SARS-pseudovirus and SARS-CoV infection.[53] In virus-infected Vero E6 cells, a siRNA against the S sequence"}